Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

Signe Stensen; Liva L. Krogh; Alexander H. Sparre-Ulrich; Flemming Dela; Bolette Hartmann; Tina Vilsbøll; Jens J. Holst; Mette M. Rosenkilde; Mikkel B. Christensen; Lærke S. Gasbjerg; Filip K. Knop

doi:10.1111/dom.14736

Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

Signe Stensen
, Liva L. Krogh
, Alexander H. Sparre-Ulrich
, Flemming Dela
, Bolette Hartmann
, Tina Vilsbøll
, Jens J. Holst
, Mette M. Rosenkilde
, Mikkel B. Christensen
, Lærke S. Gasbjerg
, Filip K. Knop (Corresponding Author)

Research output: Contribution to journal › Letter › peer-review

8 Citations (Scopus)

Original language	English
Pages (from-to)	1882-1887
Number of pages	6
Journal	Diabetes, Obesity and Metabolism
Volume	24
Issue number	9
DOIs	https://doi.org/10.1111/dom.14736
Publication status	Published - Sept 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords*

GIP
GIP receptor antagonist
GLP-1
incretin hormones
incretins
obesity
type 2 diabetes

Field of Science*

3.2 Clinical medicine

Publication Type*

1.1. Scientific article indexed in Web of Science and/or Scopus database

Access to Document

10.1111/dom.14736

https://dom-pubs-onlinelibrary-wiley-com.db.rsu.lv/doi/epdf/10.1111/dom.14736

Cite this

Stensen, S., Krogh, L. L., Sparre-Ulrich, A. H., Dela, F., Hartmann, B., Vilsbøll, T., Holst, J. J., Rosenkilde, M. M., Christensen, M. B., Gasbjerg, L. S., & Knop, F. K. (2022). Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Diabetes, Obesity and Metabolism, 24(9), 1882-1887. https://doi.org/10.1111/dom.14736

Stensen, Signe ; Krogh, Liva L. ; Sparre-Ulrich, Alexander H. et al. / Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. In: Diabetes, Obesity and Metabolism. 2022 ; Vol. 24, No. 9. pp. 1882-1887.

@article{243e03f871214841a124aa8c49a57c43,

title = "Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity",

keywords = "GIP, GIP receptor antagonist, GLP-1, incretin hormones, incretins, obesity, type 2 diabetes",

author = "Signe Stensen and Krogh, \{Liva L.\} and Sparre-Ulrich, \{Alexander H.\} and Flemming Dela and Bolette Hartmann and Tina Vilsb{\o}ll and Holst, \{Jens J.\} and Rosenkilde, \{Mette M.\} and Christensen, \{Mikkel B.\} and Gasbjerg, \{L{\ae}rke S.\} and Knop, \{Filip K.\}",

year = "2022",

month = sep,

doi = "10.1111/dom.14736",

language = "English",

volume = "24",

pages = "1882--1887",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "John Wiley and Sons Inc.",

number = "9",

}

Stensen, S, Krogh, LL, Sparre-Ulrich, AH, Dela, F, Hartmann, B, Vilsbøll, T, Holst, JJ, Rosenkilde, MM, Christensen, MB, Gasbjerg, LS & Knop, FK 2022, 'Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity', Diabetes, Obesity and Metabolism, vol. 24, no. 9, pp. 1882-1887. https://doi.org/10.1111/dom.14736

Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. / Stensen, Signe; Krogh, Liva L.; Sparre-Ulrich, Alexander H. et al.
In: Diabetes, Obesity and Metabolism, Vol. 24, No. 9, 09.2022, p. 1882-1887.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

AU - Stensen, Signe

AU - Krogh, Liva L.

AU - Sparre-Ulrich, Alexander H.

AU - Dela, Flemming

AU - Hartmann, Bolette

AU - Vilsbøll, Tina

AU - Holst, Jens J.

AU - Rosenkilde, Mette M.

AU - Christensen, Mikkel B.

AU - Gasbjerg, Lærke S.

AU - Knop, Filip K.

PY - 2022/9

Y1 - 2022/9

KW - GIP

KW - GIP receptor antagonist

KW - GLP-1

KW - incretin hormones

KW - incretins

KW - obesity

KW - type 2 diabetes

UR - https://www.scopus.com/pages/publications/85132102765

U2 - 10.1111/dom.14736

DO - 10.1111/dom.14736

M3 - Letter

C2 - 35491518

AN - SCOPUS:85132102765

SN - 1462-8902

VL - 24

SP - 1882

EP - 1887

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 9

ER -

Stensen S, Krogh LL, Sparre-Ulrich AH, Dela F, Hartmann B, Vilsbøll T et al. Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity. Diabetes, Obesity and Metabolism. 2022 Sept;24(9):1882-1887. doi: 10.1111/dom.14736

Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity

UN SDGs

Keywords*

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this